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Clinical Characteristics of a Nationwide Hospital-based Registry of 
Mild-to-Moderate Alzheimer’s Disease Patients in Korea: A CREDOS 
(Clinical Research Center for Dementia of South Korea) Study 
With rapid population aging, the socioeconomic burden caused by dementia care is 
snowballing. Although a few community-based studies of Alzheimer’s disease (AD) 
have been performed in Korea, there has never been a nationwide hospital-based 
study thereof. We aimed to identify the demographics and clinical characteristics of 
mild-to-moderate AD patients from the Clinical Research Center for Dementia of 
Korea (CREDOS) registry. A total of 1,786 patients were consecutively included from 
September 2005 to June 2010. Each patient underwent comprehensive neurological 
examination, interview for caregivers, laboratory investigations, neuropsychological 
tests, and brain MRI. The mean age was 74.0 yr and the female percentage 67.0%. 
The mean period of education was 7.1 yr and the frequency of early-onset AD (< 65 yr 
old) was 18.8%. Among the vascular risk factors, hypertension (48.9%) and diabetes 
mellitus (22.3%) were the most frequent. The mean score of the Korean version of 
Mini-Mental State Examination (K-MMSE) was 19.2 and the mean sum of box scores 
of Clinical Dementia Rating (CDR-SB) 5.1. Based on the well-structured, nationwide, 
and hospital-based registry, this study provides the unique clinical characteristics of 
AD and emphasizes the importance of vascular factors in AD in Korea.
Key Words: Alzheimer’s disease; Dementia; Multicenter study; Hospital-based study; 
Demography; Far East
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INTRODUCTION
Alzheimer’s disease (AD) is the most common cause of demen-
tia and accounts for 60%-70% of all dementias. The prevalence 
of AD in population usually increases with age, especially over 
the age of 65. Korea is among the countries with the most rapid-
ly aging population. With the increasing elderly population in 
Korea, the number of dementia patients is estimated to reach 
nearly a million by 2027, according to the report of the Ministry 
of Health, Welfare, and Family Affairs (1). Therefore, the socio-
economic burden of AD is expected to soar in the coming de-
cades and this will have an impact on the policy guidelines for 
health and welfare. So far, however, there has been no system-
ized nationwide hospital-based clinical and epidemiologic study 
undertaken for AD in the country.
  There have been several, regional and nationwide, communi-
ty-based studies of AD available in Korea (2-4). According to the 
results of these studies, age-standardized prevalence was 6%-8% 
for dementia and a particular gender (i.e. female) together with 
low level of education proved to be important risk factors for de-
mentia. However, previous researches mainly focused on the 
prevalence of dementia which led to inevitable limitations in the 
demographic data, while the results of neuroimaging studies, 
including computed tomography (CT) or magnetic resonance 
imaging (MRI) scans, were not shown in detail. In addition, they 
lacked practical information from the hospital-based registry. 
  Furthermore, the cultural and historical background of the 
Korean people is quite unique. Firstly, the Confuscian culture 
has influenced the lifestyle of Koreans for a long time since the 
Chosun Dynasty, the last kingdom of Korea dating back to the 
early fifteenth century. It was an era when women were prohib-
ited from receiving formal education and engaging in social ac-
tivities. Secondly, in the aftermath of the Korean War (1950-1953), 
the war-torn country suffered financial poverty among other 
postwar crises. Because of these historical backgrounds, the mean 
level of education of the elderly in Korea is presumed to be low. 
In addition, the recent pervasive westernized lifestyle of the aver-
age Korean daily lives is likely to increase cardiovascular or cere-
brovascular burden. Considering these peculiar situations, a 
comprehensive epidemiologic study of AD in Korea is manda-
tory in order to understand the present status of dementia and 
to draw up an effective policy for the future. 
  To meet this need, the Clinical Research for Dementia of South 
Korea (CREDOS), a clinical research group consisting of neurol-
ogists and psychiatrists specializing in dementia, has been fund-
ed by the the Ministry of Health, Welfare, and Family Affairs since 
2005. The centers included in the CREDOS have started a longi-
tudinal registry study (CREDOS study) to build up a hospital-
based registry of dementia patients. In this study we examined 
a large set of patients who have been diagnosed with mild-to-
moderate AD from the total CREDOS registry. The aim of our 
study is to identify unique demographic and clinical character-
istics of mild-to-moderate AD patients in Korea. 
MATERIALS AND METHODS
Participants
From September 2005 to June 2010, patients with mild-to-mod-
erate AD visiting the clinics for memory disorders at 31 different 
CREDOS participating centers were consecutively included. A 
total of 1,786 patients were selected based on the following in-
clusion and exclusion criteria. These patients, who were mostly 
from the out-patient clinics, and in part from the in-patient clin-
ics, were either self-referred or referred from primary clinics. All 
the patients met the probable AD criteria proposed by the Na-
tional Institute of Neurological and Communicative Disorders 
and Stroke and AD and Related Disorders Association (NINCDS-
ADRDA) (5) as well as Diagnostic and Statistical Manual of Men-
tal Disorders, Fourth edition (DSM-IV) (6). Some patients met 
both of the full diagnostic criteria for AD and subcortical vascu-
lar dementia (SVaD), which meant mixed cases. We considered 
these patients as having AD with white matter changes. The se-
verity of dementia was assessed by Clinical Dementia Rating 
(CDR) (7), and “mild-to-moderate” dementia was defined as 
CDR 0.5, 1, or 2. Each patient underwent comprehensive medi-
cal and neurological examinations. Caregivers were interviewed 
in-depth by neurologists or psychiatrists, and neuropsycholo-
gists. Patients who had clinical evidence of stroke were exclud-
ed. All the patients underwent brain MRI and the patients with 
“severe” (described later) white matter intensities were also ex-
cluded, as were patients with structural lesions such as territo-
rial infarction, intracranial hemorrhage, brain tumor, and hydro-
cephalus. Those with current or past neurological or psychiatric 
illnesses such as schizophrenia, epilepsy, brain tumor, encepha-
litis, and severe head trauma were ruled out. We left it to the phy-
sician’s judgment whether the subjects have depressive disorders 
or depressive symptoms. If the physician thought it was neces-
sary to consult a psychiatrist, he or she could do so, although not 
every participant went along with the interview with the psychi-
atrists. In this registry, all the Axis I psychiatric disorders were 
excluded. Subjects with physical illnesses or disorders that could 
interfere with the clinical study such as hearing or vision loss, 
aphasia, severe cardiac disorders, severe respiratory illnesses, 
uncontrolled diabetes, hypertension, malignancy, and hepatic 
or renal disorders were excluded. However, those with histories 
of well-treated epilepsy or syphilis or malignancies which had 
not recurred for a long time were included. 
 
Clinical evaluations
We used the Dementia Evaluation Package developed by the 
CREDOS composed of the Clinical Evaluation Form and the 
Caregiver Questionnaire Form. The Clinical Evaluation Form Park HK, et al.  •  Clinical Characteristics of Alzheimer’s Disease in Korea 
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included; 1) history of cognitive decline from the caregiver (the 
onset time was based on the time stated by the caregiver), 2) Ko-
rean version of Mini-Mental State Examination (K-MMSE) (8), 
3) CDR (7), 4) Global Deterioration Scale (GDS) (9), 5) Hachin-
ski ischemia scale (HIS), 6) neurological examinations, and 7) 
Geriatric depression scale (GDS-d) (10). The Caregiver Question-
naire Form included; 1) basic demographic data of the patient 
and caregiver, 2) lifestyle and family history, 3) past medical his-
tory including vascular risk factors such as hypertension, diabe-
tes, heart disease, hyperlipidemia, previous stroke history, alco-
hol, and smoking. Vascular risk factors were regarded as positive 
either if the patient had previously been diagnosed with associ-
ated disease or if he or she was currently under medical treatment 
for the disease. Smoking history was considered to be positive for 
both past and current smokers. However, current smokers were 
only included in statistical analysis. The Caregiver Questionnaire 
Form also included; 4) Korean Dementia Screening Question-
naire (KDSQ) (11), 5) Barthel activities of daily living (ADL) in-
dex, 6) Seoul instrumental ADL (S-IADL) (12) and 7) Korean ver-
sion of Neuropsychiatric Inventory (K-NPI) (13) (We evaluated 
the total NPI score and the frequencies of positive NPI items). 
All the patients underwent laboratory tests including complete 
blood counts (CBC), chemistry and electrolytes, lipid profile, 
urinalysis, venereal disease research laboratory (VDRL), thyroid 
function test, vitamin B12/folate, fibrinogen, and homocysteine. 
As the previous CREDOS study described, APOE genotype was 
determined by polymerase chain reaction (PCR) (14). MRI was 
also performed in all patients, as described later. At the beginning 
of this registry, the symposium was held in order to standardize 
diagnostic assessment and to ascertain inter-center and intra-
center reliability. In the middle of the registry, neurologists, psy-
chiatrists, research nurses, and psychologists had a regular meet-
ing in order to check the quality of data every 3rd Saturday.
Cognitive assessments
We examined a standardized neuropsycholgical battery, the 
Seoul Neuropsyhcological Screening Battery (SNSB) (15) in all 
patients. The SNSB contains tests for verbal and visual memory, 
visuoconstructive function, frontal/executive function, attention, 
language, praxis, and four elements of Gerstmann syndrome. 
Age-, sex-, and education-specific norms for each test based on 
447 normal subjects were available. The scores of scorable cog-
nitive tests were classified as abnormal when they were below 
the 16th percentiles of the norms. If any task in the descriptive 
items was found to be abnormal by a neuropsychologist, the do-
main was categorized as “abnormal”. We also obtained the total 
score of SNSB by a method identical to that described previous 
literatures (16), except that we modified the score of frontal/ex-
ecutive function from 70 to 60. The total score was 290 and con-
sisted of subscores from each cognitive domain as follows: atten-
tion, 17; language and related function, 27; visuospatial function, 
36; memory, 150; and frontal/executive function, 60. 
Visual rating of white matter hyperintensities
MRI was performed based on the protocol of MRI acquisition 
for CREDOS registration; T1 axial, T2 axial, fluid attenuated in-
version recovery (FLAIR) axial, gradient echo axial, and thin-slice 
(0.5-1 mm) T1 coronal series. We evaluated the severity of white 
matter hyperintensities (WMH) according to the modified Faze-
kas and Scheltens scale on the T2 axial or FLAIR images. WMH 
were evaluated in periventricular white matter (PWM, P rating) 
and deep white matter (DWM, D rating) areas separately and 
the D and P ratings were combined to provide a final ischemia 
score. DWM lesions were divided into D1 (DWM < 10 mm), D2 
(10 ≤ DWM < 25 mm), and D3 (≥ 25 mm) based on the longest 
diameter of lesions. PWM lesions were classified into P1 (cap and 
band < 5 mm), P2 (between P1 and P3), and P3 (cap or band ≥ 10 
mm) based on the size of cap and band, which were perpendic-
ular and horizontal to the ventricle, respectively. The results were 
combined to provide a representative rating as minimal (D1P1, 
D1P2), moderate (neither minimal nor severe group), or severe 
(D3P3). In our study, MRI of all patients met the rating of mini-
mal or moderate ischemia and the patients with severe ischemia 
(D3P3) were excluded. 
Statistical analyses
SPSS for Windows (version 14.0, SPSS Inc.) was used for data 
analyses. We analyzed the frequencies and the mean values of 
the variables. 
Ethics statement
The study was approved by the institutional review board of all 
participating centers. Written informed consent was obtained 
from patients and their caregivers. The approval number of this 
project in Asan Medical Center was 2007-0193. 
RESULTS
Baseline demographic and clinical characteristics
Table 1 shows the demographic and clinical characteristics of 
the 1,786 patients. The most prevalent age group was the 8th 
decade, which consisted of 926 patients (51.8%). Female patients 
attributed to 67.0% and 18.8 percent of the patients were cate-
gorized as early-onset AD (EOAD, < 65 yr old). APOE genotyp-
ing was performed in 957 patients, of whom 410 (42.8%) were 
positive for ε4 with 68 (7.1%) patients being homozygous for ε4 
and 342 (35.8%) patients being heterozygous for ε4. There were 
337 patients (18.9%) who had a family history of dementia. Pa-
tients who used the mobile phone accounted for 51.3% (917/ 
1,786), while those who drove motor vehicles represented 6.8% 
(122/1,786). Those who were known to have occupations were 
212 patients (11.9%). Regarding the body mass index (BMI), there Park HK, et al.  •  Clinical Characteristics of Alzheimer’s Disease in Korea 
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were 424 (23.7%) patients who had BMI of 25 or greater. Vision 
was preserved in 48.3% of the patients and hearing in 83.7%. 
  Among the caregivers, the spouse looked after the patient         
in 28.9%, while the son, daughter, daughter-in-law constituted 
23.9%, 26.5%, and 15.6%, respectively. Female made up 62.7% 
of the caregivers. Seven hundred and fifty-five (42.3%) caregiv-
ers did not reside with the patients. The largest age group of care-
givers was the 5th decade (503; 28.1%) while the second largest 
was the 6th decade (392; 21.9%).
Vascular risk factors and other comorbid conditions
Among the vascular risk factors, hypertension (48.9%) and dia-
betes mellitus (22.3%) were most frequent in our patients, follo-
w
 ed by current alcohol drinker (19.4%), family history of stroke 
(18.5%), cardiac disease (14.6%), and hypercholesterolemia (13.8 
%), in the order of frequency (Table 2). At least any one of these 
vascular risk factors was found in 1,106 (61.9%). The mean total 
cholesterol level was 194.8 ± 135.2 mg/mL and the mean LDL 
cholesterol level was 116.3 ± 70.3 mg/mL. Other than cardiovas-
cular risk factors, anemia (23.9%) was the most commonly asso-
ciated medical condition, followed by cancer (20.2%), renal dis-
ease (16.1%), and fracture of long bone (9.7%), in the order of fre-
quency. Depression was also one of the items of comorbidity eval-
uation and according to the patients or their caregivers, only 66 
patients (3.7%) reported to have previous or current depression.  
Characteristics of general cognition, neuropsychiatric 
symptoms, and ADL
Table 3 shows the characteristics of cognition, ADL indices, and 
neuropsychiatric symptoms of AD patients. The mean CDR and 
CDR-SB were 0.9 and 5.1, respectively. The mean K-MMSE score 
was 19.2 and the mean GDS was 4.1. The mean total score of 
SNSB-D, the mean score of verbal memory of SNSB-D, and the 
mean score of visual memory of SNSB-D was 99.0, 11.3, and 5.7, 
respectively.
  The number of patients assessed as CDR 0.5, 1, and 2 were 809 
(45.3%), 770 (43.1%) and 207 (11.6%), respectively. The number 
of patients assessed as GDS 3, 4, 5, and 6 were 404 (22.6%), 798 
(44.7%), 510 (28.6%), and 74 (4.1%). Mean Hachinski ischemic 
score was 2.4 and GDS-d was 14.8. Although there were only 66 
patients (3.7%) who had histories of previous or current depres-
sion on the comorbidity evaluation as described already, there 
were 693 patients (38.8%) who scored 18 or more on GDS-d which 
suggested clinically moderate depression, and there were 903 
patients (50.6%) with depression in NPI. Neuropsychiatric symp-
toms were found in 85.7% of the patients. Depression (50.6%), 
Table 1. Baseline demographic characteristics of mild-to-moderate AD subjects 
Characteristics Number (Percentage)
Number 1,786
Age, yr (mean ± SD)
   50-59
   60-69
   70-79
   ≥ 80
  74.0 ± 7.5 
   90 (5.0)
   340 (19.0)
   926 (51.8)
   430 (24.1)
Female 1,196 (67.0)
Age of onset, yr (mean ± SD)   71.4 ± 7.9
Early onset (age of onset < 65 yr)    336 (18.8)
Duration of illness, months (mean ± SD)     30.6 ± 27.9
Education years (mean ± SD)     7.1 ± 5.0
No education  
   Low level (≤ 6 yr)
   Intermediate level (> 6 yr, ≤ 12 yr)
   High level (> 12 yr)
 127 (7.1)
   939 (52.6)
   486 (27.2)
   234 (13.1)
Literacy
   Unable to read or write 
   Only able to read and write one’s own name
   Able to read easy terms and write one’s own name  
      and address
   Able to read fluently but makes some spelling errors
   Able to read and write fully
 
   16 (0.9)
 126 (7.1)
   218 (12.2)
   622 (34.8)
   796 (44.6)
Apo E (n = 748)
   ε2/ε2   
   ε2/ε3
   ε2/ε4
   ε3/ε3
   ε3/ε4
   ε4/ε4
 
     1 (0.1)
   62 (6.5)
   12 (1.3)
   484 (50.6)
   330 (34.5)
   68 (7.1)
Height (cm) (mean ± SD) 156.1 ± 9.6
Weight (kg) (mean ± SD)   56.9 ± 9.9
BMI (kg/m
2) (mean ± SD)
   < 20
   20-24
   ≥ 25
  23.6 ± 6.9
   258 (14.4)
   853 (47.8)
   424 (23.7)
Missing data were not included. SD, standard deviation.
Table 2. Vascular risk factors and other comorbid conditions in patients with Alzheimer’s disease based on the caregiver’s statement 
Vascular risk factors
Number  
(Percentage*, %) Associated medical conditions
Number  
(percentage*, %) Associated medical conditions
Number  
(percentage*, %)
Hypertension   872 (48.9) Anemia   426 (23.9) History of trauma 68 (3.8)
Family history of stroke   330 (18.5) Cancer   361 (20.2) Carbon monoxide (CO) poisoning 37 (2.1)
Diabetes mellitus    398 (22.3) Renal disease   288 (16.1) History of brain operation 24 (1.3)
Current alcohol drinker    347 (19.4) Gastrointestinal disorders 165 (9.3) Chronic liver disease   9 (0.5)
Hyperlipidemia   245 (13.8) Arthritis 156 (8.8) Epilepsy 20 (1.1)
Cardiac disease   260 (14.6) Fracture of long bone 174 (9.7) Compression fracture of spine   9 (0.5)
Current smoker 175 (9.8) Pulmonary disease 103 (5.7) Syphilis   7 (0.4)
History of stroke 129 (7.2) Thyroid disease   66 (3.7) Depression 66 (3.7)
*Missing values were not included. The frequency of above disorders was based on the history that the patients had been treated for these disorders previously or they were 
currently being treated.Park HK, et al.  •  Clinical Characteristics of Alzheimer’s Disease in Korea 
http://jkms.org   1223 http://dx.doi.org/10.3346/jkms.2011.26.9.1219
apathy (49.6%), irritability (42.0%), and anxiety (41.35%) were 
common among the patients with neuropsychiatric problems 
(Fig. 1). The mean Barthel ADL index was 19.0 ± 2.2 and the mean 
Instrumental ADL index in current state and in potential ability 
was 17.6 ± 9.8 and 14.4 ± 9.4, respectively. 
The ischemia rating according to D/P system
D1 was observed in 1,375 patients (77.0%) and P1 was shown in 
888 patients (49.7%). D3 was identified in only 41 patients (2.3%) 
and P3 in 499 patients (27.9%). The ischemia level was minimal 
in 1,095 patients (61.2%) and moderate in 691 patients (38.8%) 
(Table 4). 
DISCUSSION
This is the first nationwide hospital-based study depicting the 
clinicoepidemiological profile of mild-to-moderate AD in Korea. 
Up until now, obtaining a bird’s eye view of AD across the country 
had been difficult. There have been several reports on the prev-
alence and subtypes of dementia in Korea, but they were commu-
nity-based, rather than being hospital-based, and focused only 
on the clinical and neuropsychological profiles (2, 3, 17). Further-
more, even in nationally representative studies from the Western 
countries, large-sampled, hospital-based studies with in-depth 
assessment including neuroimaging studies were rare. In con-
trast, our study was based on not only clinical and comprehen-
sive neuropsychological profiles, but also neuroimaging studies.
  Old age is a well-known risk factor of AD throughout the world, 
while, in Europe and Asian countries, women have been identi-
fied to be more prone to the development of dementia (18, 19). 
The findings in our AD population were in accordance with those 
results, in that the prevalence increased with age up to the 8th 
decade and that women were affected twice as much as men. 
The largest age group involved in our study was the 8th decade, 
which possibly might have been even older had it not been for 
the higher morbidity and mortality in the older population. Those 
older than 79 yr of age are more prone to comorbid medical ill-
nesses and more severe dementia, which could make the fami-
ly members more reluctant to seek medical attention, particu-
larly the dementia clinic.
  Another interesting finding of our study is that the proportion 
of EOAD was higher than expected, accounting for 18.8% of AD. 
Given that this study was based on the hospital-based registry 
into consideration, the proportion may be overestimated. How-
ever, in Korea, studies focusing on the prevalence of early-onset 
dementia are lacking, as opposed to those on the prevalence of 
dementia in the elderly people. Therefore, the result of this study 
Table 3. Baseline characteristics of cognitive, functional and neuropsychological assessment (n = 1,786)
Characteristics Mean ± SD Minimum 25%ile 50%ile 75%ile Maximum
K-MMSE 19.2 ± 4.7 2 16 19 23   30
CDR   0.9 ± 0.5 0.5 0.5 1 1     2
CDR sum of boxes   5.1 ± 2.8 0.5 3.0 4.5 6.0   15
Global Deterioration Scale   4.1 ± 0.8 3 4 4 5     6
KDSQ 13.8 ± 6.7 0 9 13 19   30
BADL 19.0 ± 2.2 2 19 20 20   20
S-IADL-C 17.6 ± 9.8 0 10 16 24   45
S-IADL-P 14.4 ± 9.4 0 7 13 20   44
Hachinski Ischemic Scale   2.3 ± 2.8 0 1 2 3   15
K-NPI   13.9 ± 17.3 0 3 8 19 120
Geriatric Depression Scale 14.8 ± 8.0 0 8 15 22   30
SD, standard deviation; K-MMSE, Korean version of Mini-Mental State Examination; CDR, clinical dementia rating; KDSQ, Korean Dementia Screening Questionnaire; BADL, 
Barthel activities of daily living index; S-IADL-C, Seoul instrumental activities of daily living-current capacities; S-IADL-P, Seoul instrumental activities of daily living-potential ca-
pacities; K-NPI, Korean version of Neuropsychiatric inventory.
Table 4.The white matter hyperintensity rating based on D/P system
D1 (< 10 mm) D2 (in between) D3 (≥ 25 mm)
P1 (Cap/band, both 
   < 5 mm)
839 (46.9%) 39 (2.2%) 10 (0.6%)
P2 (in between) 256 (14.3%) 112 (6.3%) 31 (1.7%)
P3 (Capping/banding, 
   either ≥ 10 mm)
280 (15.7%)   219 (12.3%) 0 (0 %)
D, deep white matter hyperintensity; P, periventricular white matter hyperintensity.
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Fig. 1. The frequency of Neuropsychiatric Inventory items. Del, delusion; Hal, halluci-
nation; Agt, agitation; Dep, depression; Anx, anxiety; Eup, euphoria; Apa, apathy; Dis, 
disinhibition; Irrit, irritability; Mot, aberrant motor behavior; Sle, sleep; App, appetite.Park HK, et al.  •  Clinical Characteristics of Alzheimer’s Disease in Korea 
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could provide another important consideration in the policy-
making process. Although patients with EOAD may be affected 
more severely in terms of economical and social status, by and 
large they have been neglected in terms of facilities or govern-
ment subsidies. As mentioned earlier, the number of demented 
patients in Korea is estimated to be a million in 2027 and the 
number of AD patients will roughly reach 600,000. Therefore, the 
estimated number of EOAD patients which accounts for nearly 
one fifth of AD will be almost 120,000. Furthermore, our results 
showed that the family history of dementia was higher in early 
onset (23.9%) than in late onset AD (18.9%). In the Western coun-
tries, the incidence of probable EOAD per 100,000 was reported 
to be 7.2-22.6 (20, 21), constituting about 6% of AD patients. In 
addition to these practical implications, the clinical, genetic and 
neuroimaging profile of this population may be different from 
those of late-onset AD and should be further worked out in detail.
  Considering the strong association between vascular risk fac-
tors and AD, we need to control modifiable factors such as hy-
pertension, diabetes, and hyperlipidemia in general population 
more strictly. In this study, we found that almost half (48.9%) of 
mild-to-moderate AD had hypertension. Diabetes (22.3%) was 
the second most common vascular factor in AD patients. Hyper-
lipidemia was found in 13.8% of AD patients. MRI analysis re-
vealed that a significant portion of AD patients (38.8%) had a 
moderate degree of white matter high signal intensities, suggest-
ing that concomitant cerebrovascular lesions are not rare. There 
is growing evidence that vascular risk factors such as hyperten-
sion (22), hyperlipidemia (23), and diabetes mellitus (24) are im-
plicated in the development of AD. Composites of the risk fac-
tors seem to increase the risk for dementia in a dose-dependent 
fasion (25). In addition, identification and management of these 
vascular factors are of clinical importance since vascular factors 
may have potential modifiability and could promote clinical ex-
pressions of of AD (26). It was difficult to compare between vas-
cular factors in this study and those in the Western countries be-
cause of methological issues. The studies concerning cardiovas-
cular risk factors in AD reported in the Western world were not 
cross-sectional, but mostly longitudinal ones unlike our study. 
The results from longitudinal studies suggest that single factor 
or multiple vascular risk factors was robustly associated with the 
increased risk of dementia (23, 25). 
  Neuropsychiatric symptoms are common in AD. Several stud-
ies have estimated the prevalence of the neuropsychiatric symp-
toms of AD to be from 70% to 90% (27, 28). Apathy, depression, 
irritability and agitation were frequently reported symptoms in 
previous studies, while euphoria was the least frequent (28). In 
our study, 85.7% of the patients had exhibited at least one neu-
ropsychiatric symptom in the previous month. Depression, ap-
athy, irritability, and anxiety were the most common symptoms, 
and euphoria was the least common behavioral abnormality. 
However, as opposed to the previous studies (28) that reported 
apathy to be the number one behavioral change, depression was 
the most frequent behavioral change in our population. Accord-
ing to the structured interview for apathy, only 7% met criteria 
for apathy, which was significantly lower than other studies for 
mild dementia patients (29). Because apathy and depression are 
frequently associated and share key symptoms, it is difficult to 
make definitive distinctions between them (30). It is noted that 
when the caregivers were given a single question as to whether 
the patients had a history of previous or current depression, only 
3.7% responded “yes”. However, the figure rose to over half when 
assessed by NPI which explores the presence of depression with 
more detailed questions. Therefore, this discrepancy suggests 
that depression is the most frequent but underestimated symp-
tom in mild-to-moderate AD patients in Korea. 
  There are some limitations to this study. First of all, although it 
was a nationwide study, the results were derived from hospital-
based data, which may not represent the population as a whole, 
and consequently result in a selection bias. Therefore, the find-
ings of this study cannot be generalized to the whole Korean pop-
ulation. Secondly, there is a possibility that patients with mixed 
AD and cerebrovascular disease may have been unintentional-
ly included in our study, since we did not exclude the patients 
with moderate ischemia from the study. Up to now, there is no 
confirmative method available to differentiate these two condi-
tions on clinical grounds. Furthermore, the inclusion of AD pa-
tients with mild to moderate ischemia instead of those with no 
ischemia may better reflect AD patients in the real world, since 
it is widely believed that AD with cerebrovascular lesion is more 
common than pure Alzheimer’s disease. Thirdly, the document-
ed clinical information of the subjects included in the study lack-
ed in the data regarding the presence or absence of a family his-
tory of Down syndrome, the use of anti-oxidant agents or estro-
gen replacement, and information concerning leisure activities 
of the patients. In addition, information concerning the use of 
cholinesterase inhibitors was not available for analysis.
  This is the first attempt in Korea that has implemented a well-
designed and systemized clinico-epidemiologic study that in-
cludes laboratory tests and MRI findings, guaranteeing the di-
agnostic precision of a large number of patients labeled as mild-
to-moderate AD. This study could shed new light on the indige-
nous characteristics of AD and underline the importance of vas-
cular factors in AD in Korea. Additionally, not only will it serve 
as a reference for future epidemiological or clinical studies, it will 
also provide an important basis for government policy-making. 
Further longitudinal study using this registry is needed to inves-
tigate the natural course of AD in Korea.    
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Clinical Characteristics of a Nationwide Hospital-based Registry of Mild-to-Moderate 
Alzheimer’s Disease Patients in Korea: A CREDOS (Clinical Research Center for 
Dementia of South Korea) Study 
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Kee Hyung Park, Kyung R. Cha, Sang Won Seo and Jae-Hong Lee
This nationwide study shows the demographics and clinical characteristics of mild-to-moderate Alzheimer’s disease (AD) patients 
from the Clinical Research Center for Dementia of South Korea (CREDOS) cohort. We found that the most common age group was 
the 8th decade and the percentage of females was 67%. With regard to vascular risk factors, hypertension and diabetes were the 
most common factors in AD. Brain MRI revealed moderate white matter ischemia in about 40% of the patients, suggesting that 
mixed AD with cerebrovascular disorder may be more common than previously thought. These findings derived from the hospital-
based registry enabled us to obtain a bird’s eye view of Korean AD patients, and provided an access to more accurate demographic 
picture of AD in Korea.